Rossari Biotech Ltd
₹496.25
(0.36%)
Tue, 03 Mar 2026, 10:05 am
Process Industries
Chemicals: Specialty
24.5KRossari Biotech EV/EBITDA Ratio
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 67 | 51.61 | 30.73 | 28.55 | 24.53 |
| Price to book ratio | 0 | 0 | 0 | 0 | 13.18 | 6.25 | 3.59 | 3.56 | 2.82 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 7.59 | 3.40 | 1.99 | 2.04 | 1.61 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 113.55 | 156.65 | 22.18 | 124.50 | 26.86 |
| Enterprise value | 0 | 0 | 0 | 0 | 52.94B | 49.85B | 32.19B | 37.79B | 34.45B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 42.57 | 27.68 | 14.77 | 15.30 | 13.33 |
| Debt to equity ratio | 0.41 | 0.24 | 0.04 | 0.23 | 0 | 0.01 | 0.08 | 0.11 | 0.18 |
| Return on equity % | 0 | 34.08 | 43.32 | 31.79 | 23.07 | 16.09 | 12.47 | 13.32 | 12.21 |
Rossari Biotech Ltd Enterprise Value to EBITDA Ratio
The Rossari Biotech Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Rossari Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Rossari Biotech Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Rossari Biotech Ltd (NSE: ROSSARI, BSE: 543213) is currently trading at ₹496.25, with a market capitalization of ₹27.59B. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Rossari Biotech Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Rossari Biotech Ltd Enterprise Value to EBITDA Ratio Current Value
The current Rossari Biotech Ltd Enterprise Value to EBITDA Ratio stands at 13.33.
The Rossari Biotech Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Rossari Biotech Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Rossari Biotech Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 13.33
- 2023: 15.30
- 2022: 14.77
- 2021: 27.68
- 2020: 42.57
The decline in Rossari Biotech Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Rossari Biotech Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Rossari Biotech Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Rossari Biotech Ltd.
Rossari Biotech Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Rossari Biotech Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Rossari Biotech Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Rossari Biotech Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800